Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 6, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Rescuing neurons in prion disease.

Nicholas C Verity1, Giovanna R Mallucci

  • 1MRC Toxicology Unit, Hodgkin Building, University of Leicester, Lancaster Road, Leicester LE1 9EH, UK.

The Biochemical Journal
|December 17, 2010
PubMed
Summary

Researchers rescued neurons in mice with prion disease, reversing damage and achieving symptom-free survival. This breakthrough offers new therapeutic targets for prion and other neurodegenerative diseases by intervening early.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PERK-ATAD3A interaction provides a subcellular safe haven for protein synthesis during ER stress.

Science (New York, N.Y.)·2024
Same author

Trazodone rescues dysregulated synaptic and mitochondrial nascent proteomes in prion neurodegeneration.

Brain : a journal of neurology·2023
Same author

HNRNPH1 regulates the neuroprotective cold-shock protein RBM3 expression through poison exon exclusion.

The EMBO journal·2023
Same author

ASO targeting RBM3 temperature-controlled poison exon splicing prevents neurodegeneration in vivo.

EMBO molecular medicine·2023
Same author

Evaluating data integrity in ribosome footprinting datasets through modelled polysome profiles.

Nucleic acids research·2022
Same author

Trazodone and patient outcomes in dementia-Limitations of naturalistic cohort data.

International journal of geriatric psychiatry·2022

Area of Science:

  • Neuroscience
  • Medicine
  • Genetics

Background:

  • Neurodegenerative diseases present a growing global burden, characterized by protein misfolding and neuronal loss.
  • Current treatments are limited as patients often present with advanced, irreversible neuronal damage.
  • Understanding neurotoxicity mechanisms is crucial for developing effective therapies.

Purpose of the Study:

  • To explore therapeutic strategies for preventing neuronal loss in neurodegenerative diseases.
  • To identify and target the underlying pathogenic mechanisms in prion disease.
  • To investigate the potential for reversing established neuronal damage.

Main Methods:

  • Utilized transgenic mouse models of prion disease.
  • Employed RNA interference for gene knockdown to target pathogenic processes.
  • Assessed therapeutic efficacy through behavioral, cognitive, and neurophysiological evaluations.

Main Results:

  • Successfully rescued neurons in mice with prion disease, reversing early pathological changes.
  • Achieved complete recovery and symptom-free survival for the natural lifespan of treated animals.
  • Demonstrated that targeting the core pathogenic mechanism, not just toxic species, is effective.

Conclusions:

  • Established a novel therapeutic target for prion disease and provided insight into neurotoxicity mechanisms.
  • Discovered a critical window for reversing neuronal damage in prion disease.
  • Proposed new therapeutic concepts for other neurodegenerative disorders, emphasizing early detection of neuronal dysfunction.

More Related Videos

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain
11:29

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain

Published on: October 3, 2012

Related Experiment Videos

Last Updated: Jun 6, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain
11:29

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain

Published on: October 3, 2012